Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lipid metabolism disorders
ADR ID BADD_A01285
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
Description Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body. [MeSH]
MedDRA Code 10013317
MeSH ID D052439
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Lipid Metabolism Disorders | Lipid Metabolism Disorder | Metabolism Disorder, Lipid | Metabolism Disorders, Lipid
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02120Tazarotene--
BADD_D02147Telmisartan--
BADD_D02151Temsirolimus--
BADD_D02154Tenofovir0.006204%
BADD_D02155Tenofovir disoproxil--
BADD_D02156Tenofovir disoproxil fumarate--
BADD_D02160Terbinafine--
BADD_D02165Teriflunomide0.000362%
BADD_D02166Teriparatide--
BADD_D02170Testosterone0.000682%
BADD_D02172Testosterone enanthate--
BADD_D02173Testosterone propionate--
BADD_D02174Testosterone undecanoate--
BADD_D02192Thalidomide--
BADD_D02208Thyrotropin alfa--
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02224Tiotropium bromide--
BADD_D02225Tiotropium bromide monohydrate--
BADD_D02226Tipranavir--
BADD_D02227Tipranavir disodium--
BADD_D02229Tirofiban hydrochloride--
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02236Tofacitinib0.019602%
BADD_D02237Tofacitinib citrate--
BADD_D02241Tolcapone--
BADD_D02246Tolvaptan--
BADD_D02247Topiramate--
BADD_D02254Tramadol--
The 13th Page    First    Pre   13 14 15    Next   Last    Total 15 Pages
ADReCS-Target
ADR Term Drug Name Target